These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 22065318)
21. Optimal resection area for superior mesenteric artery nerve plexuses after neoadjuvant chemoradiotherapy for locally advanced pancreatic carcinoma. Einama T; Kamachi H; Tsuruga Y; Sakata T; Shibuya K; Sakamoto Y; Shimada S; Wakayama K; Orimo T; Yokoo H; Kamiyama T; Katoh N; Uchinami Y; Mitsuhashi T; Taketomi A Medicine (Baltimore); 2018 Aug; 97(31):e11309. PubMed ID: 30075497 [TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Breslin TM; Janjan NA; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Evans DB Front Biosci; 1998 Nov; 3():E193-203. PubMed ID: 9792895 [TBL] [Abstract][Full Text] [Related]
23. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. Pingpank JF; Hoffman JP; Ross EA; Cooper HS; Meropol NJ; Freedman G; Pinover WH; LeVoyer TE; Sasson AR; Eisenberg BL J Gastrointest Surg; 2001; 5(2):121-30. PubMed ID: 11331473 [TBL] [Abstract][Full Text] [Related]
24. Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Herman JM; Fan KY; Wild AT; Hacker-Prietz A; Wood LD; Blackford AL; Ellsworth S; Zheng L; Le DT; De Jesus-Acosta A; Hidalgo M; Donehower RC; Schulick RD; Edil BH; Choti MA; Hruban RH; Pawlik TM; Cameron JL; Laheru DA; Wolfgang CL Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):678-85. PubMed ID: 23773391 [TBL] [Abstract][Full Text] [Related]
25. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826 [TBL] [Abstract][Full Text] [Related]
26. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design. Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969 [TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemoradiation may be associated with improved pathologic response in pancreatic cancer. Hue JJ; Sugumar K; Bingmer K; Ammori JB; Winter JM; Hardacre JM Am J Surg; 2021 Mar; 221(3):500-504. PubMed ID: 33234234 [TBL] [Abstract][Full Text] [Related]
28. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Wang J; Estrella JS; Peng L; Rashid A; Varadhachary GR; Wang H; Lee JE; Pisters PW; Vauthey JN; Katz MH; Gomez HF; Evans DB; Abbruzzese JL; Fleming JB; Wang H Cancer; 2012 Aug; 118(15):3801-11. PubMed ID: 22180096 [TBL] [Abstract][Full Text] [Related]
29. Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer. Paik WH; Lee SH; Kim YT; Park JM; Song BJ; Ryu JK J Korean Med Sci; 2015 Jul; 30(7):917-23. PubMed ID: 26130955 [TBL] [Abstract][Full Text] [Related]
30. Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer. Kubota K; Sato T; Watanabe S; Hosono K; Kobayashi N; Mori R; Taniguchi K; Matsuyama R; Endo I; Nakajima A Dig Endosc; 2014 Jan; 26(1):77-86. PubMed ID: 23551230 [TBL] [Abstract][Full Text] [Related]
31. CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study. Rigiroli F; Hoye J; Lerebours R; Lafata KJ; Li C; Meyer M; Lyu P; Ding Y; Schwartz FR; Mettu NB; Zani S; Luo S; Morgan DE; Samei E; Marin D Radiology; 2021 Dec; 301(3):610-622. PubMed ID: 34491129 [TBL] [Abstract][Full Text] [Related]
32. Posterior 'superior mesenteric artery first' approach for resection of locally advanced pancreatic cancer. Rose JB; Rocha F; Alseidi A; Helton S Ann Surg Oncol; 2014 Jun; 21(6):1927-8. PubMed ID: 24370905 [TBL] [Abstract][Full Text] [Related]
33. Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. Cooper AB; Holmes HM; des Bordes JK; Fogelman D; Parker NH; Lee JE; Aloia TA; Vauthey JN; Fleming JB; Katz MH J Am Coll Surg; 2014 Jul; 219(1):111-20. PubMed ID: 24856952 [TBL] [Abstract][Full Text] [Related]
34. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Takahashi H; Ohigashi H; Ishikawa O; Gotoh K; Yamada T; Nagata S; Tomita Y; Eguchi H; Doki Y; Yano M Ann Surg; 2012 Jan; 255(1):95-102. PubMed ID: 22123160 [TBL] [Abstract][Full Text] [Related]
35. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381 [TBL] [Abstract][Full Text] [Related]
36. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis. Sung S; Kim SH; Lee JH; Nam TK; Jeong S; Jang HS; Song JH; Lee JW; Bae JM; Lee JH Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):647-653. PubMed ID: 28581407 [TBL] [Abstract][Full Text] [Related]
37. Left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma. Aimoto T; Mizutani S; Kawano Y; Matsushita A; Yamashita N; Suzuki H; Uchida E J Nippon Med Sch; 2013; 80(6):438-45. PubMed ID: 24419715 [TBL] [Abstract][Full Text] [Related]
38. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Wei D; Zaid MM; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Agrawal A; Rashid A; Wang H; Varadhachary G; Wolff RA; Tamm EP; Bhosale PR; Maitra A; Koay EJ; Wang H Pancreatology; 2021 Jan; 21(1):200-207. PubMed ID: 33221151 [TBL] [Abstract][Full Text] [Related]
39. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma. Badiyan SN; Olsen JR; Lee AY; Yano M; Menias CO; Khwaja S; Wang-Gillam A; Strasberg SM; Hawkins WG; Linehan DC; Myerson RJ; Parikh PJ Am J Clin Oncol; 2016 Feb; 39(1):1-7. PubMed ID: 26132367 [TBL] [Abstract][Full Text] [Related]
40. Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma. Lin C; Verma V; Lazenby A; Ly QP; Berim LD; Schwarz JK; Madiyalakan M; Nicodemus CF; Hollingsworth MA; Meza JL; Are C; Padussis J; Grem JL Am J Clin Oncol; 2019 Oct; 42(10):755-760. PubMed ID: 31513018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]